CSL312
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for CSL312, covering 2022-01-24 to 2026-06-02. Get the full timeline:
Most recent: Clinical Trial Results: CSL312_3003 Safety and Pharmacokinetic Study in Subjects 2 to 11 Years of Age With Hereditary Angioedema [Phase 3]